SCHEMBL25952337

SCHEMBL25952337

COc1c(C)c(O)c(C)c(O)c1C(=O)/C=C/c1ccc(F)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 2/20 0.76
▸ SLC5A1 P13866 2/20 0.51
▸ SLC5A2 P31639 2/20 0.51
▸ CTSL P07711 2/20 0.50
▸ KCNA3 P22001 2/20 0.50
▸ ALDH1A1 P00352 2/20 0.49
▸ KRAS P01116 2/20 0.49
▸ ATM Q13315 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ TNFRSF1A P19438 1/20 0.48
▸ PTGS2 P35354 1/20 0.47
▸ LMNA P02545 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ ACHE P22303 1/20 0.47
▸ BACE1 P56817 1/20 0.47
▸ CXCL12 P48061 1/20 0.47
▸ MAOA P21397 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25340515 1.00 ABCB1 (0.76) ABCB1SLC5A1SLC5A2CTSLKCNA3
SCHEMBL25953116 0.92 ABCB1 (0.64) ABCB1SLC5A1SLC5A2CTSLKCNA3
SCHEMBL662283 0.89 ABCB1 (0.80) ABCB1SLC5A1SLC5A2KCNA3ALDH1A1
SCHEMBL662284 0.89 ABCB1 (0.80) ABCB1SLC5A1SLC5A2KCNA3ALDH1A1
SCHEMBL25340278 0.89 ABCB1 (0.80) ABCB1SLC5A1SLC5A2KCNA3ALDH1A1
SCHEMBL25952345 0.89 ABCB1 (0.80) ABCB1SLC5A1SLC5A2KCNA3ALDH1A1
SCHEMBL25337768 0.88 ABCB1 (0.78) ABCB1SLC5A1SLC5A2ALDH1A1ATM
SCHEMBL25952365 0.88 ABCB1 (0.78) ABCB1SLC5A1SLC5A2ALDH1A1ATM
SCHEMBL25341084 0.87 ABCB1 (0.59) ABCB1SLC5A1SLC5A2CTSLKCNA3
SCHEMBL25952448 0.87 ABCB1 (0.59) ABCB1SLC5A1SLC5A2CTSLKCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION (KR) 2023-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248665-A1 COMPOSITION COMPRISING DIMETHYLCHALCONE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE LIPC, PC, CYP27A1 ABCB1 3180/4885SLC5A1 170/4885SLC5A2 92/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback